Sort
130,381 grants matching “hiv”
Vaccination against mucosal HIV clade C transmission
$2,163,226Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2007 · AI
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum.
$2,162,304Justin D. Radolf · University Of Connecticut Sch Of Med/Dnt · U19 · FY2021 · AI
WIHS Data Management and Analysis Center (WDMAC)
$2,162,073Stephen John Gange · Johns Hopkins University · U01 · FY2017 · AI
SPORE in Cervical Cancer
$2,162,000T.-C. Wu · Johns Hopkins University · P50 · FY2014 · CA
Immunologic control of HIV-1 through combination bNAbs and biologics.
$2,161,658Marina Caskey · Rockefeller University · U01 · FY2020 · AI
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,161,146Northwestern University · U01 · FY2002 · AI
Early Events in Alzheimer Pathogenesis
$2,161,123Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2016 · AG
Molecular Regulation Of RNA Metabolism
$2,160,908Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
HIV/SIV Data Base and Analysis Unit
$2,160,750National Institute Of Allergy And Infectious Diseases · Y01 · FY2015 · AI
Center for Applied Immunology and Pathological Processes
$2,160,125Andrew D Yurochko · Louisiana State Univ Hsc Shreveport · P20 · FY2022 · GM
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2013 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2015 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2014 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI
Center for Research on Improving the Treatment of Drug Abuse
$2,159,703Charles P O'Brien · University Of Pennsylvania · P60 · FY2011 · DA
Cellular pharmacology of tenofovir and emtricitabine for HIV prophylaxis
$2,159,561Peter Lindsay Anderson · University Of Colorado Denver · U01 · FY2011 · AI
LIVE ATTENUATED MULTIPLY DELETED HIV1 VACCINE FOR AIDS
$2,158,944Harvard University (Medical School) · P01 · FY2001 · AI
CENTER FOR PSYCHO-ONCOLOGY RESEARCH
$2,158,930University Of Miami Coral Gables · P50 · FY2002 · CA
Units for HIV/AIDS Clinical Trials Networks
$2,158,520Michael C Keefer · University Of Rochester · UM1 · FY2012 · AI
Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors
$2,158,500John K Hewitt · University Of Colorado · P60 · FY2011 · DA
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
$2,158,371David I Watkins · University Of Miami School Of Medicine · P01 · FY2012 · AI
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$2,158,015Roger L Shapiro · Harvard School Of Public Health · U01 · FY2019 · AI
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Domestic Hub
$2,157,554Edward Snyder · Yale University · N01 · FY2011 · HL
NEBRASKA CENTER FOR VIRAL PATHOGENESIS
$2,156,461University Of Nebraska Lincoln · P20 · FY2001 · RR
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D
$2,155,958David C Montefiori · Duke University · N01 · FY2013 · AI